 GARDEN CITY, NY, Jan. 18, 2021 GLOBE NEWSWIRE -- ProPhase Labs, Inc. NASDAQ: PRPH, a diversified medical science and technology company, announced today the pricing of an underwritten public offering of 3,000,000 shares of common stock at an offering price of 12.50 per share, for gross proceeds of 37,500,000. In addition, ProPhase has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares to cover over-allotments, if any. All of the shares are being offered by ProPhase. 